Smith & Nephew PLC SNNUF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $13.74
- Day Range
- $13.10–13.20
- 52-Week Range
- $13.10–18.50
- Bid/Ask
- $8.26 / $17.00
- Shares Outstanding
- 837.03M
- Market Cap
- $11.27B
- Volume/Avg
- 3,072 / 2,028
Key Statistics
- Price/Earnings (Normalized)
- 13.64
- Price/Sales
- 1.81
- Dividend Yield (Trailing)
- 3.01%
- Dividend Yield (Forward)
- 3.01%
- Dividend Payment Schedule
- May, Nov
- Total Yield
- 8.54%
Company Profile
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Core
- Total Number of Employees
- 17,000
- Website
- https://www.smith-nephew.com
Competitors
Valuation
|
Metric
|
SNNUF
|
SYK
|
JNJ
|
|---|---|---|---|
Price/Earnings (Normalized) | 13.64 | 19.57 | 23.82 |
Price/Book Value | 2.15 | 4.36 | 7.33 |
Price/Sales | 1.81 | 4.08 | 6.44 |
Price/Cash Flow | 9.27 | 18.68 | 22.07 |
Price/Earnings
SNNUF
SYK
JNJ
Financial Strength
|
Metric
|
SNNUF
|
SYK
|
JNJ
|
|---|---|---|---|
Quick Ratio | 1.11 | 1.08 | 0.73 |
Current Ratio | 2.14 | 2.16 | 1.09 |
Interest Coverage | 5.42 | — | 25.00 |
Quick Ratio
SNNUF
SYK
JNJ
Profitability
|
Metric
|
SNNUF
|
SYK
|
JNJ
|
|---|---|---|---|
Return on Assets (Normalized) | 8.51% | 11.44% | 13.42% |
Return on Equity (Normalized) | 17.09% | 23.97% | 32.69% |
Return on Invested Capital (Normalized) | 11.66% | 14.10% | 20.33% |
Return on Assets
SNNUF
SYK
JNJ
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|$J>K!c< | LOCK|&gFCr | $169B | |||
| Medtronic PLC
MDT
| LOCK|hqfGf<k | LOCK|q?^Bp | $110B | |||
| Stryker Corp
SYK
| LOCK|%^?fgVY | LOCK|^^% | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|$WM^DQ | LOCK|j%G^$ | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|BwY<tmD@ | LOCK|<X^z | $49B | |||
| DexCom Inc
DXCM
| LOCK|GQZ<!%#j | LOCK|&T^l | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|&JrpVp | LOCK|<> | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|WG! | LOCK|jW | $23B | |||
| Steris PLC
STE
| LOCK|^Jw@^Zl | LOCK|X#d! | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|b?qq>$^& | LOCK|%M# | $17B |
United States